These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3133813)

  • 1. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma.
    Koppert PW; Hoegee-de Nobel E; Nieuwenhuizen W
    Thromb Haemost; 1988 Apr; 59(2):310-5. PubMed ID: 3133813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
    Koppert PW; Kuipers W; Hoegee-de Nobel B; Brommer EJ; Koopman J; Nieuwenhuizen W
    Thromb Haemost; 1987 Feb; 57(1):25-8. PubMed ID: 2438796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A specific marker of thrombolysis: DDE complex].
    Soria J; Soria C; Mirshahi M; Mirshahi M; Boucheix C; Pujade E; Perrot JY; Samama M; Bernadou A; Caen JP
    C R Acad Sci III; 1987; 304(11):307-11. PubMed ID: 3103876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody-based quantitative enzyme immunoassay for the determination of plasma fibrinogen concentrations.
    Hoegee-de Nobel E; Voskuilen M; Briët E; Brommer EJ; Nieuwenhuizen W
    Thromb Haemost; 1988 Dec; 60(3):415-8. PubMed ID: 3070825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differentiation between fibrin degradation products and fibrinogen degradation products by using newly developed ELISAs].
    Isogai N; Yamagishi T; Kaku M; Matsumoto K; Yamamoto Y; Kuroso K; Arai M; Yorifuji H; Fukutake K; Fujimaki M
    Rinsho Byori; 1991 Jul; 39(7):753-7. PubMed ID: 1920869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE
    Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
    Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid monoclonal antibody-based enzyme immunoassay (EIA) for the quantitative determination of soluble fibrin in plasma.
    Nieuwenhuizen W; Hoegee-De Nobel E; Laterveer R
    Thromb Haemost; 1992 Sep; 68(3):273-7. PubMed ID: 1440491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific determination and identification of cross-linked fibrin degradation products in patients under thrombolytic therapy for myocardial infarction.
    Soria J; Soria C; Mirshahi M; Xi M; Mirshahi M; Samama MM; Caen JP
    Semin Thromb Hemost; 1987 Apr; 13(2):223-7. PubMed ID: 3114888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
    Dyr JE; Cajthamlová H; Suttnar J
    Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products.
    Madoiwa S; Kitajima I; Ohmori T; Sakata Y; Mimuro J
    Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
    Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
    Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unreliability of current serum fibrin degradation product (FDP) assays.
    Gaffney PJ; Perry MJ
    Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.